Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$13.98 - $29.25 $587 - $1,228
42 Added 32.06%
173 $4,000
Q1 2022

May 13, 2022

BUY
$23.58 - $30.91 $495 - $649
21 Added 19.09%
131 $3,000
Q4 2021

Feb 11, 2022

SELL
$20.0 - $32.29 $120 - $193
-6 Reduced 5.17%
110 $3,000
Q3 2021

Feb 11, 2022

SELL
$16.48 - $27.23 $906 - $1,497
-55 Reduced 32.16%
116 $3,000
Q2 2021

Feb 11, 2022

BUY
$20.0 - $25.48 $3,420 - $4,357
171 New
171 $4,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.